RELISTOR
RELISTOR
Approved
DIN Number
02356503
Drug Class
Human
Market Date
N/A
Company
HC
SALIX PHARMACEUTICALS INC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02356503
AIG Number0152456001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A06AH01 METHYLNALTREXONE BROMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification56:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
METHYLNALTREXONE BROMIDEActive
Strength: 20 MG / ML
Monograph: METHYLNALTREXONE BROMIDE